Genetic predisposition to atherothromboses in patients with severe angina pectoris
- 作者: Chumakova G.A1,2, Momot A.P1,3, Kozarenko A.A1,2, Veselovskaya N.G2,4
-
隶属关系:
- Altai State Medical University, Barnaul
- Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo
- Altai Branch, Hematology Research Center, Russian Academy of Medical Sciences
- Altai Territorial Cardiology Dispensary, Barnaul
- 期: 卷 1, 编号 1 (2010)
- 页面: 80-83
- 栏目: Articles
- URL: https://journal-vniispk.ru/2221-7185/article/view/44989
- DOI: https://doi.org/10.26442/CS44989
- ID: 44989
如何引用文章
全文:
详细
作者简介
G. Chumakova
Altai State Medical University, Barnaul; Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo
A. Momot
Altai State Medical University, Barnaul; Altai Branch, Hematology Research Center, Russian Academy of Medical Sciences
A. Kozarenko
Altai State Medical University, Barnaul; Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo
N. Veselovskaya
Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo; Altai Territorial Cardiology Dispensary, Barnaul
参考
- Fu L, Jin H, Song K et al. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Chin Med J 2001; 114 (3): 266–69.
- Boekholdt S.M., Bijsterveld N.R., Moons A.H. et al. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 2001; 104: 3063–8.
- Zhan M, Zhou Y, Han Z. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China. Chin Med J 2003; 116 (11): 1707–10.
- Gardemann A, Lohre J, Katz N et al. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost 1999;82 (3): 1121–6.
- Doggen C.J., Bertina R.M., Manger Cats V., et al. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with MI. Thromb Haemost 1999; 82: 115–20.
- Hoekstra T, Geleijnse J.M., Kluft C et al. 4G/4G genotype of PAI-1 gene is associated with reduce risk of stroke in elderly. Stroke 2003; 34: 2822–8.
- Anderson J.L., Muhlestein J.B., Habashi J et al. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J Am Coll Cardiol 1999; 34: 1778–83.
- Gardemann A, Arsic T, Katz N, Tillmanns H. The factor II G20210A and factor V G1691A gene transitions and coronary heart disease. Tromb Haemost 1999; 81 (2): 208–13.
- Ozmen F, Ozmen M.M., Ozalp N, Akar N. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ulus Travma Acil Cerrahi Derg 2009; 15 (2): 113–9.
- Settin A, Dowaidar M, Abd-Al-Samad A et al. Frequency of factor V Leiden mutation in Egyptian cases with myocardial infarction. Hematology 2008; 13 (3): 170–4.
- Pastana C.L., Torres A, Blanco S et al. Factor V Leiden and the risk of venous thrombosis, myocardial infarction, and stroke: a case - control in Venezuela. Genet Test Mol Biomarkers 2009; 13 (4): 537–42.
- Ardissino D, Peyvandi F, Merlini P.A. et al. Factor V mutation in young survivors of MI. Tromb Haemost 1996; 75(5): 701–2.
- Момот А.П., Цывкина Л.П., Елыкомов В.А. и др. Ранние ишемические инсульты и гематогенные тромбофилии. Методическое пособие для врачей 2009; 23–5.
补充文件
